Bank of Montreal’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bank of Montreal’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-44,600	Closed	-$377K	–	4479
2015 Q3	$377K	Buy	+44,600	New	+$411K	﹤0.01%	1986
2015 Q1	–	Sell	-36,800	Closed	-$622K	–	4247
2014 Q4	$622K	Buy	+36,800	New	+$536K	﹤0.01%	1951
2014 Q2	–	Sell	-27,300	Closed	-$325K	–	4862
2014 Q1	$325K	Buy	27,300 +10,300	+61%	+$138K	﹤0.01%	2282
2013 Q4	$235K	Buy	+17,000	New	+$240K	﹤0.01%	2169

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of Montreal's INFI Position: Q2 2019 in Review

Bank of Montreal sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2019, closing a stake of 400 shares — an estimated $1K sold.

Bank of Montreal first reported a position in INFI in Q4 2013 and held it in 8 quarters. The position peaked at $608K in Q4 2014. 55 funds tracked by Wall St. Rank hold INFI as of Q2 2019.

Bank of Montreal reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Bank of Montreal sold 400 Infinity Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
Bank of Montreal first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 8 quarters.
Bank of Montreal's Infinity Pharmaceuticals, Inc. position peaked at $608K in Q4 2014.
55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.